RE, A., P, P., AT, S., AM, G., PC, F., AA, G., . . . DB, S. (2026). Outcomes following definitive treatment of malignant peripheral nerve sheath tumor are significantly worse for patients with neurofibromatosis type 1: A Canadian Sarcoma Research and Clinical Collaboration study. Cancer, 132(3), e70263. https://doi.org/10.1002/cncr.70263
Chicago Style (17th ed.) CitationRE, Aubrey, Psarianos P, Santiago AT, Griffin AM, Ferguson PC, Gupta AA, Peretz Soroka H, and Shultz DB. "Outcomes Following Definitive Treatment of Malignant Peripheral Nerve Sheath Tumor Are Significantly Worse for Patients with Neurofibromatosis Type 1: A Canadian Sarcoma Research and Clinical Collaboration Study." Cancer 132, no. 3 (2026): e70263. https://doi.org/10.1002/cncr.70263.
MLA (9th ed.) CitationRE, Aubrey, et al. "Outcomes Following Definitive Treatment of Malignant Peripheral Nerve Sheath Tumor Are Significantly Worse for Patients with Neurofibromatosis Type 1: A Canadian Sarcoma Research and Clinical Collaboration Study." Cancer, vol. 132, no. 3, 2026, p. e70263, https://doi.org/10.1002/cncr.70263.